Initiation of dolutegravir plus lamivudine in ART-naive adults with high HIV-1 viral load or severe immunosuppression: prevalence of use and efficacy versus DTGor BIC-based triple therapy

Initiation of dolutegravir plus lamivudine in ART-naive adults with high HIV-1 viral load or severe immunosuppression: prevalence of use and efficacy versus DTGor BIC-based triple therapy

Por favor gira tu dispositivo para ver correctamente la web. Gracias